Comparative Clinical Analysis of COVID-19 and Influenza

The global emergence of COVID-19 has prompted rigorous comparison with seasonal influenza to inform both clinical management and public health response. While both illnesses present as acute respiratory infections with overlapping symptoms such as fever, cough and myalgia, COVID-19 generally exhibits a broader spectrum of disease severity, including multisystem complications. Patients with COVID-19 tend to be younger on average and may present with fewer pre-existing conditions yet experience longer hospital stays, higher requirements for respiratory support and elevated rates of intensive care unit admission. Laboratory profiles often differ: lymphopenia and elevated inflammatory markers are more pronounced in COVID-19, whereas influenza may more frequently be associated with elevated procalcitonin. Radiological imaging further distinguishes the two: peripheral, bilateral ground-glass opacities are characteristic of COVID-19, whereas influenza is more commonly associated with dense consolidations. Age, comorbidity profile and vaccination status substantially influence outcomes in both diseases, and coinfection scenarios pose additional diagnostic and therapeutic challenges. Understanding these distinctions is critical for optimising triage, allocating healthcare resources and designing targeted vaccination and antiviral strategies, particularly as both viruses continue to co-circulate globally.

Research from Nature Portfolio

Deep phenotyping across international hospital networks has provided granular characterisation of patients admitted with COVID-19 versus seasonal influenza. In a large multinational cohort exceeding 30,000 individuals, COVID-19 admissions were more often male in some regions, younger and with fewer chronic conditions, yet they required more advanced respiratory interventions and exhibited distinct medication profiles compared with influenza admissions. In a direct hospital-based comparison of seasonal influenza and early COVID-19 cases, patients with COVID-19 demonstrated a longer duration of hospitalisation, a greater need for supplemental oxygen and invasive ventilation, and a higher incidence of intensive care admission. Notably, immunocompromised individuals with COVID-19 experienced disproportionately high mortality relative to their influenza counterparts, underscoring the importance of protective measures in vulnerable populations.

Comparative Clinical Analysis of COVID-19 and Influenza publication trend

The graph below shows the total number of articles in comparative clinical analysis of covid-19 and influenza across all publications each year (not limited to Nature Index journals).

Technical terms

Ground-glass opacity: a hazy area on chest CT imaging indicating partial filling of air spaces or interstitial thickening without complete obscuration of underlying vessels.

Comorbidity: one or more additional medical conditions coexisting with a primary disease, affecting prognosis and management.

Prospective cohort study: an observational design in which a defined group of individuals is followed over time to assess specific health outcomes.

References

1. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nature Communications (2020).
2. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Scientific Reports (2021).
3. Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study. Clinical Infectious Diseases (2023).
4. A Comparative Systematic Review of COVID-19 and Influenza. Viruses (2021).